Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FDA’s New Orphan Products Director Brings Industry, Legal, Academic, Regulatory Background
Aug 02 2021
•
By
Derrick Gingery
The FDA has a new director of the Office of Orphan Products Development. • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Agency Leadership
More from Pink Sheet